C12N 2770/32041
Use of virus, viral particle or viral elements as a vector
C12N2770/32041 (Use of virus, viral particle or viral elements as a vector) appears on 9 US grants and 27 published applications in this corpus.
Search patents in C12N- Granted patents
- 9
- Published applications
- 27
- Assignees
- 26
- Inventors
- 96
- Latest grant
- 11 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 1 |
| 2018 | 2 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 2 |
| 2021 | 0 | 2 |
| 2022 | 2 | 2 |
| 2023 | 0 | 3 |
| 2024 | 1 | 5 |
| 2025 | 3 | 3 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2770/32042Virus or viral particle as vehicleIndexing code4
- C12N 2770/32043Viral genome or elements thereof as genetic vectorIndexing code3
- C12N 2770/32044Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code1
- C12N 2770/32045Special targeting system for viral vectorsIndexing code1
Recent patents
- Pharmaceutical composition containing stabilized nucleic acid adjuvant11 Nov 2025US 12,465,644 B2Sml Biopharm Co., Ltd.
- Optimized CYP4V2 gene and application thereof15 Jul 2025US 12,357,706 B2Suzhou Nggt Biotechnology Co., Ltd.
- Non-covalent loading of plant picovirus particles11 Mar 2025US 12,247,228 B2Case Western Reserve University
- Pseudotyped insect baculovirus gene transfer system and pseudotyped baculovirus for shrimps, construction method and use thereof8 Oct 2024US 12,110,497 B2Ocean University of China
- Enhanced expression of RNA vectors27 Dec 2022US 11,534,417 B2The University Court of the University of Edinburgh
- Artificial secoviridae satellite rnas1 Oct 2026US 2026/0297596 A1Flagship Pioneering Innovations Vii, LLC
- Production of rna polynucleotides encoding picornavirus11 Sep 2025US 2025/0281556 A1ElevateBio Technologies, Inc.
- Replicon Compositions and Methods of Using Same for the Treatment of Diseases11 Sep 2025US 2025/0281602 A1BioNTech SE
- Coxsackievirus b4 strain and application thereof9 Jan 2025US 2025/0009867 A1Institute of Medical Biology, Chinese Academy of Medical Sciences
- Compounds, compositions, and methods of using thereof7 Nov 2024US 2024/0366518 A1ElevateBio Technologies, Inc.
Most cited
By later US patents
- Non-covalent loading of plant picornavirus particles3US 10,590,394 B2Case Western Reserve University · 2020
- Gene-modified coxsackievirus1US 10,076,547 B2Kyushu University, National University Corporation · 2018
- Non-covalent loading of plant picovirus particles1US 11,371,025 B2Case Western Reserve University · 2022